Arkolith/Insider Trading/DALS/Form 4

ARCH Venture Partners XI, L.P.

10% OwnerDA32 Life Science Tech Acquisition Corp. (DALS) · full profile →Form 4 · filed Aug 3, 2021
Net Buying
Open-Market Buys
$16.0M
Open-Market Sells
$0
Net Open-Market Flow
$16.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 30, 2021Buy(P)1.6M$10.00$16.0M1.6M
Jul 30, 2021Other(J)650K$10.00$6.5M2.3M

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-031417) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML